HomeNBRVF • OTCMKTS
add
Nabriva Therapeutics PLC - ADR
Previous close
$0.00020
Market cap
650.00 USD
Avg Volume
330.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Revenue | 2.24M | — |
Operating expense | 4.11M | — |
Net income | -12.06M | — |
Net profit margin | -537.76 | — |
Earnings per share | — | — |
EBITDA | -12.01M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.18M | — |
Total assets | 10.58M | — |
Total liabilities | 26.90M | — |
Total equity | -16.32M | — |
Shares outstanding | 3.23M | — |
Price to book | -0.00 | — |
Return on assets | -172.18% | — |
Return on capital | 306.80% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2023info | Y/Y change |
|---|---|---|
Net income | -12.06M | — |
Cash from operations | 511.00K | — |
Cash from investing | -50.00K | — |
Cash from financing | 0.00 | — |
Net change in cash | 334.00K | — |
Free cash flow | 4.93M | — |
About
Founded
2005
Website
Employees
39
